Pandemblock Oy
Developing preventive intranasal antivirals targeting respiratory viruses globally.
Oversigt
- Ukendt
- Medarbejdere
- Ukendt
- Omsætning
- 2021
- Grundlagt
Nøglebeslutningstagere
Pasi Kemppainen
Business Development and Partner Relations, Founder
Kalle Saksela
Scientific Advisor
Anna R. Mäkelä
CEO and Founder
Beskrivelse
Pandemblock Ltd is a biotechnology company spun out from the University of Helsinki in the fall of 2021. The organization is dedicated to developing innovative, affordable antiviral intranasal inhibitors aimed at improving pandemic preparedness and control. Their core technology is the proprietary S...
Tags
Nøgleord
Teknologistak
Virksomhedsoplysninger
- Branche
- Ukendt
- Juridisk form
- 16
- Momsnummer
- FI32428191
Beslutningstagere
3 kontakter i FunnelfeedrPasi Kemppainen
Business Development and Partner Relations, Founder
Kalle Saksela
Scientific Advisor
Anna R. Mäkelä
CEO and Founder
Lignende virksomheder
20 lignende virksomheder i Funnelfeedr
Virenc Holding AB
Developing novel peptide therapeutics against enveloped viruses for global health.
ROKOTE LABORATORIES FINLAND OY
Developing universal intranasal vaccines to block respiratory virus infection effectively.
1928 Diagnostics AB
5 medarbejdereDelivering fast bioinformatics solutions to fight antimicrobial resistance effectively.
Gedea Biotech AB
5–9 medarbejdereSwedish biotech developing antibiotic-free BV treatment pHyph.
QureTech Bio AB
5–9 medarbejdereDeveloping novel synthetic antibiotics to combat drug-resistant bacteria.
Udforsk mere
Spørgsmål om Pandemblock Oy
Vil du se Funnelfeedr i aktion?
Book en gratis demo og opdag, hvordan Funnelfeedr hjælper dig med at finde og konvertere dine ideelle kunder.
Book en demo